ChengDu ShengNuo Biotec Company Description

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs.

The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate.

ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

ChengDu ShengNuo Biotec Co.,Ltd.

Country	China
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,450
CEO	Yongjun Wen

Contact Details

Address: No. 98, Da'an Road, Dayi County Chengdu, Sichuan Province 611330 China
Phone	86 28 8820 3630
Website	snbiopharm.com

Stock Details

Ticker Symbol	688117
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000051M8
SIC Code	2834

Key Executives

Name	Position
Yongjun Wen	Chairman and GM
Li Wu	Chief Financial Officer, Deputy GM and Director
Xiaoli Wang	Director and Deputy General Manager
Xiaohai Yu	Deputy GM, Board Secretary and Director
Changliang Lu	Deputy General Manager
Zhonggang Ma	Deputy General Manager
Yang Shi	Accounting Supervisor